Susan McLaughlin-Beltz, Ph.D
NH Child Prescribing Practitioner/NCT
Consultant Clinical Neuropsychologist
Director of RCRS
Dr. McLaughlin-Beltz earned her Bachelor of Arts Degree in Psychology from the University of Lowell in Lowell, MA, where she graduated cum laude in 1984. She received her Masters of Arts degree in Psychology from Southern Connecticut State University in May 1998 and then worked as the clinical director of a vocational rehabilitation center for adults with mental health issues and developmental challenges. She also worked extensively in the Massachusetts courts, state psychiatric hospitals, and community treatment facilities.
Dr. McLaughlin-Beltz received her Ph.D. in Behavioral Neuroscience from Boston University School of Medicine in June 1998. She completed comprehensive training in the specialties of neuro-developmental disorders, neuropsychological assessment, psychopharmacology, lead toxicity, and behavioral teratology. Her pre-doctoral training included internships with the Boston University Autism Team and the Boston City Hospital Pediatric AIDS Team, where she provided neurodevelopmental assessments for children and participated in multidisciplinary research protocols. Dr. McLaughlin-Beltz completed post-doctoral training in neuropsychological assessment of children and adolescents, conducting competency evaluations, and emergency crisis intervention at Greater Lawrence Mental Health Center and the Lawrence District Court.
Dr. McLaughlin-Beltz has directed emergency crisis centers and is currently a regional team leader for the NH State Disaster Behavioral Response Team. She has training and experience in critical incident stress management and treatment of persons suffering from trauma.
Dr. McLaughlin-Beltz provides neuropsychological and psychological services to individuals and families. She specializes in the evaluation and treatment of children and adolescents. Her specialty areas include Autism, ADHD, Asperger's, nonverbal learning disabilities, head injury, trauma, epilepsy, metabolic (mitochondrial) disorders, cortical vision impairment, and learning disabilities.